Top Markets
Coin of the day
Nordicus Partners Corporation Nordicus Partners Corporation

Nordicus Partners Corporation

NORD
株式のランク #23226
Nordicus Partners Corporation functions as a publicly traded entity that acts... Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
株価
$4.06
最終同期: 2026-08-21
時価総額
$76.69M
変化(1日)
-0.98%
変化(1年)
125.56%
US
取引 Nordicus Partners Corporation (NORD)

カテゴリー

Nordicus Partners Corporation(NORD)の利益
2026 時点の利益 TTM: 0
Nordicus Partners Corporation の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Nordicus Partners Corporation の利益の推移(2026 〜 2026)
各年末の利益
利益 変化
提供された日付のデータは十分ではありません。
同業他社の利益
企業 利益 利益の差
$867.49M -
CH
$940.90M -
US
$940.98M -
FR
$1.03B -
US
$897.00M -
US